Benefit from Avastin in Bowel Cancer Could be Predicted by Protein Levels

Until now there has been no way of predicting the benefit of Avastin, or Bevacizumab, in bowel cancer although it has been shown to increase survival.

Until now there has been no way of predicting the benefit of Avastin, or Bevacizumab, in bowel cancer although it has been shown to increase survival in around ten to 15 per cent of patients with the condition.

Avastin works by targeting and blocking the VEGF-A protein, two major forms of which are VEGF165 and VEGF165b.

Irritable Bowel Syndrome – Causes, Diagnosis, Treatment
Irritable bowel syndrome (IBS) causes recurrent abdominal pain or discomfort and a fluctuating disturbance in defecation. IBS is not life threatening.

VEGF165 helps cancers to grow new blood vessels, so they can get food and oxygen from the blood - all cancers need a blood supply to be able to survive and grow. Its sister protein, VEGF165b, has the opposite effect and acts as a brake on this growth.

Cancer Research UK funded scientists at the University of Bristol looked at the effect Avastin had on patients with different levels of VEGF165b and compared this with patients who were not given the drug at all.

Those with low levels of VEGF165b survived three months longer without the disease progressing compared to patients not treated with Avastin. But patients with higher levels of the protein saw no benefit from Avastin and survived no longer than as those who were not given the drug.

Small bowel atresia - Types - Diagnosis - Treatment - Operation - Effect
The small bowel is the section of bowel between the stomach and the large bowel (colon). It is about 300cm long in a newborn baby at term and its function is to absorb food.

Avastin blocks both forms of VEGF-A, so in patients with lower levels of VEGF165b more Avastin may be available to block the blood vessel promoting protein VEGF165, eventually starving the cancer.

Professor David Bates, lead researcher from the University of Bristol's School of Physiology and Pharmacology, said: "Avastin has shown great potential for a minority of people with bowel cancer, but it's been impossible to predict who will benefit from the drug. Currently, Avastin is not approved by NICE for patients with advanced bowel cancer because they feel that the benefit to an unknown minority of patients does not justify the cost of treatment.

Constipation - Causes Symptoms Diagnosis Treatment FAQs | Medindia
Constipation, or difficulty passing stool, is a common digestive complaint and is a symptom of gastrointestinal abnormalities and preventing constipation is done by treating underlying disease.

"We now need to look at cancer samples from a larger group of patients about to start taking Avastin and determine if the amount of VEGF165b can accurately identify those patients that will benefit and so potentially open a new treatment option for some people with advanced bowel cancer."

Bowel cancer is the third most common cancer in the UK with around 41,000 people diagnosed each year. Survival rates have doubled over the last 40 years but 16,000 people still die from the disease.

Diverticulosis/Diverticulitis-Symptoms-Complications-Diagnosis-Treatment-FAQs
Diverticulosis is characterized by sac-like outpouching in the intestinal wall. Inflammation of diverticula results in diverticulitis.

Dr Julie Sharp, senior science information manager at Cancer Research UK, said: "New targeted treatments can be hugely beneficial for certain patients, depending on the characteristics of their tumour. But, we don't always know who these patients are. This work takes researchers a step closer to developing a suitable test so doctors can give Avastin to those people it will really make a difference to."

Source-Eurekalert